Myeloid Malignancies

DR. Hourigan'S LAB
CONTACT
Research in the Laboratory of Myeloid Malignancies, led by Dr. Christopher Hourigan, focuses on three complementary approaches that are united by an overriding theme of performing translational human immunology research in order to find ways to detect, prevent and treat acute myeloid leukemia (AML) relapse.